Table 1 The patient clinical characteristics, baseline demographics and laboratory indictors
Factor | Patients (%) |
|---|---|
|  | Total n = 54 |
Gender | |
Male | 44(81%) |
Female | 10(19%) |
Age, median (range, years) | 68 (37–78) |
≥ 65 | 31(57%) |
< 65 | 23(43%) |
Histological subtype | |
Lung cancer | 38(70%) |
Esophageal cancer | 13(24%) |
Pleural mesothelioma | 2(4%) |
Breast cancer | 1(2%) |
Smoking history | |
Never smoke | 28(52%) |
Former/current smoker | 26(48%) |
ECOG performance status | |
0–1 | 23(43%) |
≥ 2 | 31(57%) |
AJCC stage | |
IA | 1(2%) |
IB | 2(4%) |
IIA | 2(4%) |
IIIA | 7(13%) |
IIIB | 16(29%) |
IIIC | 6(11%) |
IV | 20(37%) |
Combined with corticosteroid | |
Yes | 11(20%) |
No | 43(80%) |
Combined with antibiotic or antifungal drug | |
Yes | 7(13%) |
No | 47(87%) |
Oxygen saturation, % | 95 (93–97) |
Respiratory rate | 23(17–29) |
Respiratory support | |
No ventilator support* | 26(48%) |
Non-invasive ventilation | 28(52%) |
Laboratory parameters | |
White blood cell, x 10^9/L | 5.9(3.4–9.6) |
Lymphocyte, x 10^9/L | 1.6(0.1–3.2) |
IL-6, pg/mL | 11.6(2.4–154) |
Ferritin, ng/mL | 305(11.2–1550) |
C-reactive protein, mg/L | 11.7(0.3-104.6) |
Lactate dehydrogenase, u/L | 241(144–1245) |